Vincerx Pharma Inc VINCU:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/09/21 EST
30.90quote price arrow down-30.90 (-100.00%)
52 week range
8.82 - 31.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close30.90
  • 52 Week High31.00
  • 52 Week High Date02/08/21
  • 52 Week Low8.82
  • 52 Week Low Date03/20/20
  • Market Cap282.12M
  • Shares Out9.13M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)760.21%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Vincerx Pharma Inc News

There is no recent news for this security.

Latest VINCU News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Vincerx Pharma, Inc., formerly Vincera Pharma, Inc., is a clinical-stage life sciences company. The Company focuses on the development and oncology knowledge to advance new therapies for the treatment of cancer. The Company’s small molecule drug program includes VIP152, a clinical-stage positive transcription elongation factor beta/cyclin-dependent kinase 9 (PTEFb/CDK9) inhibitor. Its antibody-drug conjugate (ADC) platform includes VIP943 (targeting CD123) and VIP924...
Address
260 Sheridan Avenue, Suite 400
Palo Alto, CA
94306
United States